Yutaka Seino

30.2k total citations · 5 hit papers
558 papers, 22.4k citations indexed

About

Yutaka Seino is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Yutaka Seino has authored 558 papers receiving a total of 22.4k indexed citations (citations by other indexed papers that have themselves been cited), including 304 papers in Endocrinology, Diabetes and Metabolism, 228 papers in Surgery and 222 papers in Molecular Biology. Recurrent topics in Yutaka Seino's work include Pancreatic function and diabetes (207 papers), Diabetes Treatment and Management (199 papers) and Metabolism, Diabetes, and Cancer (142 papers). Yutaka Seino is often cited by papers focused on Pancreatic function and diabetes (207 papers), Diabetes Treatment and Management (199 papers) and Metabolism, Diabetes, and Cancer (142 papers). Yutaka Seino collaborates with scholars based in Japan, United States and Denmark. Yutaka Seino's co-authors include Yuichiro Yamada, Daisuke Yabe, Nobuya Inagaki, Mitsuo Fukushima, Hiroo Imura, Susumu Seino, Takashi Kadowaki, Yasuhiko Iwamoto, Chikako Ito and Kohei Kaku and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Yutaka Seino

549 papers receiving 21.7k citations

Hit Papers

Report of the Committee on the Classification and Diagnos... 2002 2026 2010 2018 2010 2002 2010 2010 2022 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
    2010 1.5k citations Yutaka Seino, Takashi Kadowaki et al. Journal of Diabetes Investigation profile →
  2. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus
    2002 637 citations Yutaka Seino, Takashi Kadowaki et al. profile →
  3. GIP and GLP‐1, the two incretin hormones: Similarities and differences
    2010 544 citations Yutaka Seino, Daisuke Yabe et al. Journal of Diabetes Investigation profile →
  4. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus
    2010 520 citations Yutaka Seino, Takashi Kadowaki et al. profile →
  5. Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
    2022 145 citations Nobuya Inagaki, Yutaka Seino et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yutaka Seino Japan 71 11.2k 8.5k 7.2k 3.1k 2.7k 558 22.4k
Suad Efendić Sweden 65 9.1k 0.8× 6.1k 0.7× 6.8k 0.9× 3.5k 1.1× 2.4k 0.9× 399 18.6k
Tina Vilsbøll Denmark 73 14.9k 1.3× 7.0k 0.8× 8.1k 1.1× 3.4k 1.1× 1.9k 0.7× 455 20.3k
Eiichi Araki Japan 64 7.6k 0.7× 9.4k 1.1× 5.7k 0.8× 3.4k 1.1× 3.1k 1.1× 300 21.4k
Juris J. Meier Germany 69 12.0k 1.1× 5.9k 0.7× 8.1k 1.1× 2.5k 0.8× 1.2k 0.5× 208 17.2k
Sten Madsbad Denmark 87 17.0k 1.5× 7.1k 0.8× 11.7k 1.6× 7.1k 2.3× 2.1k 0.8× 545 27.6k
Ira D. Goldfine United States 67 6.9k 0.6× 10.5k 1.2× 4.9k 0.7× 3.6k 1.2× 2.1k 0.8× 279 20.5k
Filip K. Knop Denmark 74 12.4k 1.1× 6.0k 0.7× 7.7k 1.1× 3.7k 1.2× 2.3k 0.9× 552 18.8k
David A. D’Alessio United States 79 12.8k 1.1× 5.8k 0.7× 8.2k 1.1× 7.2k 2.3× 1.7k 0.6× 254 23.2k
André Scheen Belgium 67 10.7k 1.0× 5.3k 0.6× 4.5k 0.6× 3.9k 1.3× 2.6k 1.0× 759 19.9k
Louis M. Havekes Netherlands 84 5.8k 0.5× 7.5k 0.9× 7.7k 1.1× 5.3k 1.7× 4.0k 1.5× 422 23.1k

Countries citing papers authored by Yutaka Seino

Since Specialization
Citations

This map shows the geographic impact of Yutaka Seino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Seino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Seino more than expected).

Fields of papers citing papers by Yutaka Seino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Seino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Seino. The network helps show where Yutaka Seino may publish in the future.

Co-authorship network of co-authors of Yutaka Seino

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Seino. A scholar is included among the top collaborators of Yutaka Seino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Seino. Yutaka Seino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seino, Yutaka, et al.. (2025). Pathogenesis of type 2 diabetes in Japan and East Asian populations: Basic and clinical explorations. Proceedings of the Japan Academy Series B. 101(2). 68–74. 1 indexed citations
2.
Yamada, Yuichiro, Hiroki Fujita, Atsushi Araki, et al.. (2023). Efficacy and Safety of 6-Month High Dietary Protein Intake in Hospitalized Adults Aged 75 or Older at Nutritional Risk: An Exploratory, Randomized, Controlled Study. Nutrients. 15(9). 2024–2024. 5 indexed citations
3.
Haraguchi, Takuya, Hitoshi Kuwata, Yusuke Seino, et al.. (2022). Association of dipeptidyl peptidase‐4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan. Journal of Diabetes Investigation. 14(1). 67–74. 6 indexed citations
4.
Takahashi, Harumi, Norihide Yokoi, Yoshiyuki Hamamoto, et al.. (2021). Glutamate is an essential mediator in glutamine‐amplified insulin secretion. Journal of Diabetes Investigation. 12(6). 920–930. 24 indexed citations
5.
Seino, Yutaka, Kohei Kaku, Takashi Kadowaki, et al.. (2021). A randomized, placebo‐controlled trial to assess the efficacy and safety of sitagliptin in J apanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin. Diabetes Obesity and Metabolism. 23(6). 1342–1350. 3 indexed citations
6.
7.
Yabe, Daisuke & Yutaka Seino. (2015). Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation. Expert Opinion on Drug Safety. 15(2). 249–264. 6 indexed citations
8.
Itoh, Kazue, et al.. (2014). High saturated fatty acid intake induces insulin secretion by elevating gastric inhibitory polypeptide levels in healthy individuals. Nutrition Research. 34(8). 653–660. 17 indexed citations
9.
10.
Fukuda, Masahiro, et al.. (2010). Aspartame-Acesulfame K-containing Low-Energy Erythritol Sweetener Markedly Suppresses Postprandial Hyperglycemia in Mild and Borderline Diabetics. Food Science and Technology Research. 16(5). 457–466. 8 indexed citations
11.
Nishimura, Fusanori, Atsuhiko Taniguchi, Yoshihiko Soga, et al.. (2006). Periodontal Infection and Dyslipidemia in Type 2 Diabetics: Association with Increased HMG-CoA Reductase Expression. Hormone and Metabolic Research. 38(8). 530–535. 22 indexed citations
12.
Nishimura, Shuzo, et al.. (2005). Cost of Medical Care of Type 2 Diabetes Mellitus Outpatients : Effect of Healthcare Reform on the Diabetes Clinic. 48(9). 677–684. 2 indexed citations
13.
Yasuda, Koichiro, Nobumasa Iwanaka, Eitaro Nakamura, et al.. (2002). Abnormality in fibre type distribution of soleus and plantaris muscles in non‐obese diabetic Goto‐Kakizaki rats. Clinical and Experimental Pharmacology and Physiology. 29(11). 1001–1008. 59 indexed citations
14.
Miura, Toshihiro, Motoshi Kato, Naoki Iwamoto, et al.. (2000). Effect of Epinephrine on GLUT2 Protein Content in Mouse Liver.. Biological and Pharmaceutical Bulletin. 23(11). 1374–1376. 3 indexed citations
15.
Adachi, Tetsuya, Koichiro Yasuda, Yoshimasa Okamoto, et al.. (2000). T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats. Metabolism. 49(8). 990–995. 76 indexed citations
16.
Fukuda, Kazuhito, et al.. (1999). Adrenomedullin promotes epithelial restitution of rat and human gastric mucosa in vitro. Peptides. 20(1). 127–132. 22 indexed citations
17.
Namba, Noriyuki, et al.. (1997). The inwardly rectifying potassium channel subunit Kir2.2v (KCNJN1) maps to 17p11.2→p11.1. Cytogenetic and Genome Research. 79(1-2). 85–87. 5 indexed citations
18.
Yasuda, Koichiro, Nobuya Inagaki, Yuichiro Yamada, et al.. (1994). Hamster Gastric Inhibitory Polypeptide Receptor Expressed in Pancreatic Islets and Clonal Insulin-Secreting Cells: Its Structure and Functional Properties. Biochemical and Biophysical Research Communications. 205(3). 1556–1562. 40 indexed citations
19.
Ishida, Hitoshi, Kiyoshi Suzuki, Yoshimichi Someya, et al.. (1993). Possible compensatory role of parathyroid hormone-related peptide on maintenance of calcium homeostasis in patients with non-insulin-dependent diabetes mellitus. European Journal of Endocrinology. 129(6). 519–524. 17 indexed citations
20.
Ozono, Keiichi, Yutaka Seino, Hideki Yano, Yuichi Yamaoka, & Yoshiki Seino. (1990). 1,25-Dihydroxyvitamin D3Enhances the Effect of Refeeding on Steady StatePreproinsulin Messenger Ribonucleic Acid Levels in Rats*. Endocrinology. 126(4). 2041–2045. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suad Efendić Breakdown of academic impact, for papers by Tina Vilsbøll Breakdown of academic impact, for papers by Eiichi Araki Breakdown of academic impact, for papers by Juris J. Meier Breakdown of academic impact, for papers by Sten Madsbad Breakdown of academic impact, for papers by Ira D. Goldfine Breakdown of academic impact, for papers by Filip K. Knop Breakdown of academic impact, for papers by David A. D’Alessio Breakdown of academic impact, for papers by André Scheen Breakdown of academic impact, for papers by Louis M. Havekes
Rankless by CCL
2026